Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on CANADIAN NATL RAILWAY CO. We currently have 19 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
CANADIAN NATL RAILWAY CO
CANADIAN NATL RAILWAY CO
1Q16 Carloads Down 6.4% y/y; Adjusted 1Q16 EPS of $0.93; 12 MTP of $87.50/sh, Downgrade to Market Perform
23 Mar 16
We expect CN carloads to be down 6.4% in 1Q16 y/y as result of significant declines in metals and minerals, coal and petroleum products. Due to exposure to commodity prices impacting shipping volumes, we expect a 3.6% y/y decline in 1Q16 revenue, down to $2.99 billion. We predict 1Q16 adjusted diluted EPS of $0.93/share, in line with consensus, which represents an increase of 7% when compared to 1Q15. Due to changes to our expectations, we have lowered our 12-month target price to $87.50/share, down from our previous estimate of $90.00/share. With the shares up 12% since our upgrade, CNR receives a Market Perform ranking.
CANADIAN NATIONAL RAILWAY COMPANY (CNR) DETAILS ITS $2.9 BILLION OF CAPITAL INVESTMENT FOR 2016
10 Feb 16
On February 10, 2016, CN announced further details of its 2016 capital investment guidance of $2.9 billion. CN plans to spend $1.5 billion on track infrastructure, $600 million on rolling stock equipment, $400 million on Positive Train Control (PTC) technology, and $400 million on other initiatives. CN will spend 52% of its capital investment or $1.5 billion on track infrastructure, including replacements of rail and ties, bridge maintenance (this alone took $100 mm in 2015, or about $500,000/bridge-mile) and targeted branch line upgrades.
CANADIAN NATIONAL RAILWAY COMPANY (CNR) ANNOUNCES SHARE REPURCHASE UNDER NCIB
05 Feb 16
On Friday February 5, 2016, after market close, CN announced that it will repurchase a portion of its common stock under a specific share repurchase program, which will form part of CN's 12-month normal course issuer bid (NCIB) totaling 33 million shares announced on October 27, 2015. The daily repurchases will cap out at 1,500,000 of CN common shares with the bids running from March 1, 2016 to March 11, 2016. CN will be purchasing the common shares from a third party at a price that will be negotiated but ultimately lower than current market value at the time of the bid.
4Q15 Adj. EPS of $1.18 Beats Consensus ($1.11)/ FCC ($1.09) Estimates, Operating Ratio of 57.2% Lower than Consensus (57.9%)/FCC (58.4%) Estimates
27 Jan 16
CN has proven its capacity to operate efficiently and produce at the bottom line. Based on our new estimates and an NAV (Atax, 8%) of $89.37 per share, we have increased our 12-month target price to $90.00 per share and upgraded our ranking to Outperform.
CANADIAN NATIONAL RAILWAY COMPANY (CNR) SUBMITS ENVIRONMENTAL IMPACT STATEMENT FOR PROPOSED MILTON LOGISTICS HUB
07 Jan 16
On Thursday January 7, after market close, CN announced that it has submitted an Environmental Impact Statement (EIS) for its proposed $250 million logistics hub in Milton, ON, to the Canadian Environmental Assessment Agency (CEAA). The EIS outlines specific measures that CN plans to follow in an effort to limit the project's environmental impact on the community and demonstrates commitment to the project.
N+1 Singer - T. Clarke - Strong conclusion to FY16, record order book
28 Mar 17
After significant upgrades at the time of the full year update (PBT forecast +43% FY16; +14% FY17), today’s results are c.4% ahead of our expectations at the PBT level and show strong growth on the prior year (PBT +48%). All regions achieved positive growth in revenue. The outlook statement refers to a still growing order book (£350m at the end of February vs. £330m at the year end) and the strength of recent trading, with London & the South East and Scotland said to be particularly positive. The Group has reiterated its ambitions to improve margins, but we have not incorporated this into our forecasts at this stage. We have nudged up our FY’17 forecasts (PBT +5%) and introduced FY’18 forecasts that imply 2% PBT growth. Despite the well justified bounce in the share price, the shares still trade at a significant discount to the peer group (7.6x FY17 PE, 4% yield).
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
28 Mar 17
ClearStar* (CLSU): Building a background for growth (CORP) | Sound Energy (SOU): TE-8 results (HOLD) | LiDCO* (LID): 2017 should be a transformative year (CORP) | Proteome Sciences* (PRM): FY 2016 in line. Moving towards breakeven (CORP) | Fulcrum (FCRM): Significant market potential, rising margins and a strong balance sheet (BUY) | Mortgage Advice Bureau (MAB1): Strong and growing intellectual property (BUY) | 7digital* (7DIG): Open offer result (CORP)